Needham & Company Maintains a 'Hold' on Intuitive Surgical (ISRG); This Isn't MAKO, But Macro Not Helpful
Tweet
Share
E-mailGet Alerts ISRG Hot Sheet
Price: $394.51 -1.68%
Rating Summary:
33 Buy, 8 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
33 Buy, 8 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Needham & Company maintains a 'Hold' on Intuitive Surgical (NASDAQ: ISRG) price target of $535.00.
Analyst, Jason R. Mills, said, "We look for ISRG to exceed seemingly conservative consensus Q2 estimates of $520M/$3.53. We model $525M/$3.64, which implies revenue/EPS growth of 23%/25%, and op-margins of 40%. We expect ISRG’s Q2 results to once again be best-of-breed in med-tech land, but believe current valuation fully accounts for strong results and modest upside to consensus."
"This isn't MAKO Surgical (Nasdaq: MAKO), but the macro isn't helpful either. With an installed base over 2200 WW vs. MAKO’s ~120 and applications for daVinci in a different stratosphere vs. MAKO, ISRG and MAKO are hardly comparable. That said, MAKO's negative Q2 pre-announcement noted a lengthening sales cycle and need for additional surgeon support, which we think is applicable to ISRG in new applications (e.g., single-site, thoracic) and new geographies (e.g., Europe, Japan)."
For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.
Shares of Intuitive Surgical closed at $531.77 yesterday.
Analyst, Jason R. Mills, said, "We look for ISRG to exceed seemingly conservative consensus Q2 estimates of $520M/$3.53. We model $525M/$3.64, which implies revenue/EPS growth of 23%/25%, and op-margins of 40%. We expect ISRG’s Q2 results to once again be best-of-breed in med-tech land, but believe current valuation fully accounts for strong results and modest upside to consensus."
"This isn't MAKO Surgical (Nasdaq: MAKO), but the macro isn't helpful either. With an installed base over 2200 WW vs. MAKO’s ~120 and applications for daVinci in a different stratosphere vs. MAKO, ISRG and MAKO are hardly comparable. That said, MAKO's negative Q2 pre-announcement noted a lengthening sales cycle and need for additional surgeon support, which we think is applicable to ISRG in new applications (e.g., single-site, thoracic) and new geographies (e.g., Europe, Japan)."
For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings news on Intuitive Surgical click here.
Shares of Intuitive Surgical closed at $531.77 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent (COHR) PT Raised to $420 at Needham
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- New Street Research Upgrades Micron Technology (MU) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
